
TransHeps AG
Schlieren, Switzerland transheps.com From their website, Nov 2026
Work here? Claim this listing
About
TransHeps AG provides DILI causality assessment and related advisory services for clinical trials and pharmacovigilance. It serves global pharma and biotech companies as well as CROs from Weiningen, Zurich, Switzerland.
TransHeps AG is based in Schlieren, Switzerland, founded in 2022. It lists 6 services, including iDILI causality assays, Mechanistic in-vitro studies and Expert Advisory Services.
Services
iDILI causality assays
Patient-specific DILI causality assessment for clinical trials and pharmacovigilance.
Mechanistic in-vitro studies
In vitro studies to investigate DILI risk and underlying mechanisms of liver toxicity.
Expert Advisory Services
Consulting on DILI signal analysis, hypothesis generation, experimental design, data analysis, reporting, and integration of MetaHeps technology into clinical study design.
MetaHeps assay support
Application and logistics support for using the MetaHeps assay in clinical studies, including trial design, sample preparation, shipment, data analysis, data interpretation, and reporting.
Transporter inhibition assays
Monolayer, vesicular, and transwell assays for hepatocellular transporter inhibition, including OATP1B1, OATP1B3, OATP2B1, NTCP, BSEP, MRP2, and MDR3.
Mitochondrial dysfunction assays
Glucose/Galactose ATP assays in HuH7, HepG2, and other cell lines upon request.
- Turnaround
- 1 day to 3 weeks
- What to send
- 30-50mL of fresh blood sample or frozen PBMCs from patients
How to order from TransHeps AG
What to send, as they list it: 30-50mL of fresh blood sample or frozen PBMCs from patients. Turnaround they state: 1 day to 3 weeks. They take quote requests by email. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- DILI causality assessment
- Pharmacovigilance
- Drug-drug interaction assessment
- Transporter inhibition
- Mitochondrial dysfunction
- LDH release
- Glucose/galactose ATP assay
- Scale and capacity
- 30-50mL fresh blood sample or frozen PBMCs
- 12-14 days
- 2 days
- 1 day
- 2-3 weeks
- Therapeutic areas
- Drug safety
- Hepatology
Modalities and species
- Species and models
- HuH7
- HepG2
- MetaHeps cells
- Frozen PBMCs
- 2D human hepatocytes
- 3D human liver spheroids
- iPS-derived human hepatocytes
Industries served
- Pharma
- Biotech
- CRO
Details
- Founded
- 2022
- Office
- Badenerstrasse 48, 8104 Weiningen, Zurich, Switzerland
- Sites
- Weiningen, Switzerland
- Zurich, Switzerland
- Serves
- Global